Polyadenylate sequences of human rhinovirus and poliovirus RNA and cordycepin sensitivity of virus replication.
The polyadenylate [poly(A)] content of the genome RNA of human rhinovirus type 14 (HRV-14) is nearly twice as large as that of the genome RNA of poliovirus type 2. The poly(A) content of viral RNA was determined to be the RNase-resistant fraction of 32P-labeled viral RNA extracted from purified virions. Polyacrylamide gel electrophoresis indicated that the poly(A) sequences of HRV-14 are more heterogenous and on an average larger than those of poliovirus RNA. On the basis of susceptibility to micrococcal polynucleotide phosphorylase the rhinovirus genome terminates in poly(A). Replication of both viruses is almost totally inhibited by cordycepin at 50 mug/ml. At lower concentrations, rhinovirus replication is more sensitive to cordycepin than poliovirus replication. Addition of cordycepin (75 mug/ml) to infected culture prior to or during viral RNA replication results in more or less complete inhibition of virus-specific RNA synthesis. The results do not indicate that cordycepin sensitivity of either virus is due to preferential inhibition of viral poly(A) synthesis by this antibiotic.
D001483:Base Sequence; D003839:Deoxyadenosines / Q000494:pharmacology*; D006801:Humans; D017955:Poliovirus / Q000032:analysis* / Q000254:growth & development / Q000378:metabolism; D011061:Poly A / Q000032:analysis*; D012367:RNA, Viral / Q000032:analysis* / Q000096:biosynthesis; D012229:Rhinovirus / Q000032:analysis* / Q000254:growth & development / Q000378:metabolism; D014779:Virus Replication / Q000187:drug effects*
D003839:Deoxyadenosines; D012367:RNA, Viral; D011061:Poly A